Wondering how to use Sunesis in a sentence? Below are 4 example sentences from authentic English texts. .
Sunesis in a sentence
Using Sunesis
- In the example corpus, sunesis often appears in combinations such as: sunesis pharmaceuticals.
Context around Sunesis
- Average sentence length in these examples: 21.3 words
- Position in the sentence: 1 start, 3 middle, 0 end
- Sentence types: 4 statements, 0 questions, 0 exclamations
Corpus analysis for Sunesis
- In this selection, "sunesis" usually appears in the middle of the sentence. The average example has 21.3 words, and this corpus slice is mostly made up of statements.
- Around the word, rating and pharmaceuticals stand out and add context to how "sunesis" is used.
- Recognizable usage signals include expect that sunesis pharmaceuticals will and hold rating sunesis pharmaceuticals currently. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "sunesis" sits close to words such as aaas, aacc and aacs, which helps place it inside the broader word index.
Example types with sunesis
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Sunesis Pharmaceuticals has a one year low of $0.20 and a one year high of $1.98. (18 words)
Finally, Wells Fargo & Company MN boosted its position in shares of Sunesis Pharmaceuticals by 42.7% in the 2nd quarter. (20 words)
On average, sell-side analysts expect that Sunesis Pharmaceuticals will post -0.28 earnings per share for the current year. (20 words)
Five investment analysts have rated the stock with a hold rating, Sunesis Pharmaceuticals currently has a consensus rating of “Hold” and an average price target of $2. (27 words)
Finally, Wells Fargo & Company MN boosted its position in shares of Sunesis Pharmaceuticals by 42.7% in the 2nd quarter. (20 words)
On average, sell-side analysts expect that Sunesis Pharmaceuticals will post -0.28 earnings per share for the current year. (20 words)
Example sentences (4)
Finally, Wells Fargo & Company MN boosted its position in shares of Sunesis Pharmaceuticals by 42.7% in the 2nd quarter.
Five investment analysts have rated the stock with a hold rating, Sunesis Pharmaceuticals currently has a consensus rating of “Hold” and an average price target of $2.
On average, sell-side analysts expect that Sunesis Pharmaceuticals will post -0.28 earnings per share for the current year.
Sunesis Pharmaceuticals has a one year low of $0.20 and a one year high of $1.98.
Common combinations with sunesis
These word pairs occur most frequently in English texts: